Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2021

Summary

Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2021 This bill imposes labeling requirements on cosmetics intended for professional use, requires research on health issues relating to cosmetics, and addresses related issues. The Food and Drug Administration (FDA) must require (1) the labeling for cosmetics intended for professional use to include the name of each ingredient in descending order of predominance; and (2) the manufacturer, distributor, or seller of such a cosmetic to provide this information on its website. The Occupational Safety and Health Administration must issue a standard requiring each manufacturer or importer selling a cosmetic intended for professional use to (1) obtain or develop a safety data sheet for the cosmetic in various languages; and (2) make the data sheet available to relevant distributors and employers, such as hair salon owners. The standard must also require employers to make the data sheet available to employees exposed to the product and provide to employees versions of the sheet in languages other than English upon request. The FDA must conduct (or award grants for) research into chemicals linked to adverse health effects and most commonly found in cosmetics that are (1) marketed to women and girls of color; or (2) used by professional nail, hair, and beauty salon workers. The FDA must also award grants to support research focused on designing safer cosmetic chemicals, such as those with no inherent toxicity. The FDA must take actions to ensure that cosmetics marketed to women and girls of color are in full compliance with FDA requirements.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 8 October 2021

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 8 October 2021

   Introduced

   Introduced in House

   Source: IntroReferral

3. 8 October 2021

   Introduced

   Introduced in House

   Source: IntroReferral

4. 11 October 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 8 October 2021 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 8 October 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 8 October 2021

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 8 October 2021

  Open at official source

Sponsors

• Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
• Sen. Blunt Rochester, Lisa [D-DE] · D · Sponsor
• Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
• Sean Maloney · D · Cosponsor
• Daniel Kildee · D · Cosponsor
• Raúl Grijalva · D · Cosponsor
• Rep. Clarke, Yvette D. [D-NY-9] · D · Cosponsor
• Rep. Meng, Grace [D-NY-6] · D · Cosponsor
• Jesús García · D · Cosponsor
• Rep. Jayapal, Pramila [D-WA-7] · D · Cosponsor
• Rep. Raskin, Jamie [D-MD-8] · D · Cosponsor
• Shontel Brown · D · Cosponsor
• Rep. Chu, Judy [D-CA-28] · D · Cosponsor
• CAROLYN MALONEY · D · Cosponsor
• · hsif00 · Standing
• · hsed00 · Standing

Related records

No cross-record relationships stored yet.